Generics - Pharmaceutical


Current filters:


Popular Filters

26 to 50 of 566 results

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”


Eyal Desheh, acting president and chief executive of the world’s largest generics maker Teva (NYSE:…

CopaxoneGenericsInterviewsManagementPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Japan’s MoF seen as another opponent to premium system

Japan’s MoF seen as another opponent to premium system


The Budget Bureau of Japan’s Ministry of Finance, in a meeting of the Fiscal System Council last week,…


Increase in chronic and lifestyle-associated diseases to Brazil market sales

Increase in chronic and lifestyle-associated diseases to Brazil market sales


Brazil has emerged as a manufacturing hub for pharmaceutical and biotechnology companies, with the pharma…

GenericsPharmaceuticalSouth America

Teva gets favorable Copaxone patent ruling in Netherlands

Teva gets favorable Copaxone patent ruling in Netherlands


The District Court of the Hague has issued a favorable ruling for Teva Pharmaceutical Industries in a…


Modest growth forecast for Greek pharma market, despite unstable economy


The growing prevalence of chronic diseases and an increasing elderly population will boost the Greek…

EuropeGenericsHealthcareMarkets & MarketingPharmaceuticalPricing

Promising outcome of EU platform on access to medicines in Africa


The Platform on Access to Medicines in Developing Countries with a Focus on Africa took a step forward…

EuropeFinancialGenericsHealthcarePharmaceuticalRest of the World

Increase of Japan's medical expenditure slowed to 1.7% in 2012


The Japanese Ministry of Health, Labor and Welfare (MHLW) reported approximate medical expenditure (AME)…


Canada's Health Minister sets out plan to help reduce impact of drug shortages


A national protocol for the public notification of drug shortages and a toolkit that identifies steps…

GenericsHealthcareNorth AmericaPharmaceuticalRegulation

Advance Pharmaceutical to invest $25 million in building plant in Russia


USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility…

Advance PharmaceuticalEuropeFinancialGenericsPharmaceuticalProduction

Adcock Ingram agrees takeover terms with CFR


Adcock Ingram (AIP: SP), one of South Africa's largest drugmakers, has provided further details of the…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Avanir Pharma patent settlement with Wockhardt


USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Bayer in settlement over Cipro pricing


A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

Avanir Pharma settles Nuedexta patent litigation with Actavis


USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) says that it has entered into a settlement agreement…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceutical

UNITAID helps accessing quality drugs at affordable prices


At an interactive session with Indian pharmaceuticals and diagnostics industry leaders organized by the…


Russian billionaire to acquire control of Veropharm


Roman Avdeev, a well-known Russian banker and one of the country's richest people, has agreed to acquire…

GenericsMergers & AcquisitionsPharmaceuticalVeropharm

Lundbeck files appeal over EC pay-for-delay fine


Denmark-based CNS specialist drugmaker Lundbeck (LUND: CO) has filed its appeal against the European…


Teva to drop development of Nuvigil in bipolar 1 disorder


Israel-based leading generics company Teva Pharmaceutical Industries (NYSE: TEVA) has released disappointing…

armodafinilCephalonGenericsNeurologicalNuvigilPharmaceuticalResearchTeva Pharmaceutical Industries

Endo Health expends $225 million on generic acquisition


USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that that its Qualitest…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsPharmaceutical

Pharmstandard commits $30 million to Argos Therapeutics; post 1st-half results


Russia's largest drugmaker Pharmstandard (PHST: RU) that its subsidiary Pharmstandard International.(Luxembourg)…

AGS-003Argos TherapeuticsFinancialGenericsOncologyPharmaceuticalPharmstandardResearch

Aid group urges countries not to trade away health as TPP negotiations intensify


The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…


Horizon Pharma in Duexis patent settlement


Horizon Pharma (Nasdaq: HZNP) says it has entered into settlement and license agreements with Par Pharmaceutical…

Anti-Arthritics/RheumaticsDuexisGenericsHorizon PharmaNorth AmericaPar PharmaceuticalPatentsPharmaceutical

US FDA accepts Pennsaid 2% NDA for review


The US Food and Drug Administration has accepted for filing US drugmaker Mallinckrodt's (NYSE: MNK) New…

Anti-Arthritics/RheumaticsGenericsMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceuticalRegulation

26 to 50 of 566 results

Back to top